Cervical adenosquamous carcinoma
MONDO:0006134An uncommon carcinoma arising from the cervix. It is composed of malignant glandular epithelial cells and malignant squamous epithelial cells.
Also known as: adenosquamous cell carcinoma of cervix, adenosquamous cell carcinoma of cervix uteri, adenosquamous cell carcinoma of the cervix, adenosquamous cell carcinoma of the cervix uteri, adenosquamous cell carcinoma of the uterine cervix, adenosquamous cell carcinoma of uterine cervix, cervical adenosquamous cancer, cervical adenosquamous carcinoma
2857 clinical trials for this condition and its sub-types, 16 tagged with Cervical adenosquamous carcinoma itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Part of
Sub-types of Cervical adenosquamous carcinoma
-
Can pulsed radiation extend life in metastatic cervical cancer?
Disease control CompletedResearchers are testing a radiation technique called PULSAR in people with metastatic cervical cancer. PULSAR delivers radiation in short bursts to pelvic tumors, guided by imaging, alongside standard systemic therapy. The trial aims to see whether this approach improves overall …
Phase 2 • Sponsor: University of Texas Southwestern Medical Center • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
Immunotherapy boosts standard treatment for aggressive cervical cancer
Disease control CompletedThis early-phase trial tested whether adding the immunotherapy drug atezolizumab before and during standard chemoradiation could help control advanced cervical cancer that has spread to lymph nodes. Forty participants received the combination to see if it activated the immune sys…
Phase 1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC